Showing results (1101-1110 of 1,350) with videos related to

Sort By:
Pageof 135
Breast Cancer Research and Treatment|February 5, 2026
Refined risk stratification in residual triple-negative breast cancer after neoadjuvant therapy using residual cancer burden class and lymphovascular invasionTae Hoon Lee, Hyunwoo Lee, Jeong Yun Jang, et al.
Medical Oncology (Northwood, London, England)|November 2, 2005
Gemcitabine plus carboplatin in patients with advanced non-small cell lung cancerSe Hoon Park, Seong Hwan Jeong, Sun Young Kyung, et al.
Journal of Korean Medical Science|June 18, 2002
Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for advanced gastric carcinomaEun Kyung Cho, Woon Ki Lee, Do Yoon Lim, et al.
Gut and Liver|May 13, 2015
Esophageal Squamous Cell Carcinoma Patients Have an Increased Risk of Coexisting Colorectal NeoplasmsMyong Ki Baeg, Myung-Gyu Choi, Yun Duk Jung, et al.
Radiation Oncology Journal|July 4, 2019
Risk factors for locoregional recurrence in patients with pathologic T3N0 rectal cancer with negative resection margin treated by surgery aloneJong Yun Baek, Jeong Il Yu, Hee Chul Park, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 1, 2012
Bone marrow involvement is predictive of infusion-related reaction during rituximab administration in patients with B cell lymphomaJunshik Hong, Ji Yeon Kim, Hee Kyung Ahn, et al.
Diabetes, Obesity & Metabolism|August 14, 2025
Efficacy and safety of pioglitazone, empagliflozin and glimepiride as third-line agents in patients with type 2 diabetes inadequately controlled with metformin and DPP-4 inhibitors: A multicentre, phase 4 randomized controlled trialYun Kyung Cho, Jae-Hyoung Cho, Sang-Mo Hong, et al.
Rheumatology International|March 12, 2016
Incidence and risk factors of fractures in patients with rheumatoid arthritis: an Asian prospective cohort studyDam Kim, Soo-Kyung Cho, Chan-Bum Choi, et al.
Nanotechnology|March 7, 2020
WO3-ZnO and CuO-ZnO nanocomposites as highly efficient photoanodes under visible light illuminationTrang Nguyen Thi Thuy, Soo Kyung Cho, Yerkezhan Amangeldinova, et al.
The Korean Journal of Internal Medicine|September 11, 2010
Pemetrexed versus gefitinib versus erlotinib in previously treated patients with non-small cell lung cancerJunshik Hong, Sun Young Kyung, Sang Pyo Lee, et al.
Pageof 135